Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (209) 209
Newspaper Article (73) 73
Book / eBook (6) 6
Book Chapter (5) 5
Conference Proceeding (3) 3
Report (2) 2
Patent (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (110) 110
life sciences & biomedicine (88) 88
humans (45) 45
female (37) 37
male (35) 35
middle aged (26) 26
aged (25) 25
analysis (18) 18
physical sciences (18) 18
abridged index medicus (17) 17
risk factors (17) 17
animals (14) 14
cardiac & cardiovascular systems (14) 14
cardiovascular system & cardiology (14) 14
mortality (14) 14
general & internal medicine (12) 12
medicine, general & internal (12) 12
patients (12) 12
physics (11) 11
surgery (11) 11
health aspects (10) 10
pharmacology & pharmacy (10) 10
research article (10) 10
technology (10) 10
auger (9) 9
biological and medical sciences (9) 9
cardiovascular disease (9) 9
endocarditis (9) 9
infective endocarditis (9) 9
observatory (9) 9
adult (8) 8
astrophysics (8) 8
cardiovascular diseases (8) 8
care and treatment (8) 8
clinical trials (8) 8
double-blind method (8) 8
epidemiology (8) 8
gene expression (8) 8
heart attacks (8) 8
medical sciences (8) 8
microbiology (8) 8
myocardial infarction (8) 8
research (8) 8
spain (8) 8
stroke (8) 8
astronomy & astrophysics (7) 7
chemistry (7) 7
cytokines (7) 7
diabetes (7) 7
drug therapy (7) 7
engineering (7) 7
environmental sciences (7) 7
environmental sciences & ecology (7) 7
genetics & heredity (7) 7
genomes (7) 7
health risk assessment (7) 7
health risks (7) 7
infectious diseases (7) 7
medical research (7) 7
science (7) 7
social sciences (7) 7
studies (7) 7
[phys.astr]physics [physics]/astrophysics [astro-ph] (6) 6
acute coronary syndromes (6) 6
aged, 80 and over (6) 6
astronomy and astrophysics (6) 6
evidence-based medicine (6) 6
gastroenterology & hepatology (6) 6
genes (6) 6
incidence (6) 6
medicine & public health (6) 6
medicine, experimental (6) 6
mice (6) 6
neurosciences & neurology (6) 6
parkinsons disease (6) 6
acute coronary syndrome (5) 5
adolescent (5) 5
anticoagulants (5) 5
cardiology (5) 5
cardiovascular diseases - mortality (5) 5
cardiovascular diseases - prevention & control (5) 5
cerebral infarction (5) 5
cosmic ray experiments (5) 5
diabetes mellitus (5) 5
disease control (5) 5
drugs (5) 5
fibrosis (5) 5
follow-up studies (5) 5
genomics (5) 5
heart (5) 5
inflammation (5) 5
life sciences (5) 5
mutation (5) 5
neurodegenerative diseases (5) 5
parkinson's disease (5) 5
physics - high energy astrophysical phenomena (5) 5
physics, particles & fields (5) 5
prospective studies (5) 5
risk assessment (5) 5
spain - epidemiology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
by Dagenais, Gilles R and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Riesmeyer, Jeffrey S and Riddle, Matthew C and Rydén, Lars and Dyal, Leanne and Chung, Namsik and Conget, Ignacio and Cushman, William C and Hancu, Nicolae and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Lanas, Fernando and Cardona Munoz, Ernesto German and Pogosova, Nana and Shaw, Jonathan E and Temelkova-Kurktschiev, Theodora and Alebuena, Andrea and Almagro, Sandra and Bustamante Labarta, Miguel and Bustos, Betina and Cantero, Maria and Costamagna, Osvaldo and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dominguez, Andrea and Fernandez, Alberto and Gallardo, Karina Beatriz and Garcia Duran, Ruben and Gerbaudo, Claudio and Giotto, Ana Paula and Godoy Bolzán, Pedro and Hermida, Sonia and Hrabar, Adrian and Ingaramo, Adrián and Krynski, Mario and Lagrutta, Mariana and Lanchiotti, Paulina and Matias, Re and Pruyas, Lorena and Ricotti, Carola and Rodriguez, Carolina and Romero Vidomlansky, Mariano and Ronderos, Ricardo and Sadowski, Ana Laura and Sala, Jorgelina and Sernia, Virginia and Sicer, Maximiliano and Smith, Tomas and Stival, Jorge and Vallejos, Julio and Virgillito, Luciana and Vogel, Daniel and Zucchiatti, Noemi and Colquhoun, David and Davis, Timothy and Fourlanos, Spiros and Jeffries, William and Lo, Clement and Makepeace, Ashley and Marope, Dolly and Pillai, Satish and Reutens, Anne and Sheikh, Abdul and Smith, Greg and Castro, Denise Ludovico da Costa de and Correa da Cruz, Ivan and Costa, Midiã and Cunha, Sidney and de Carvalho Camara Bona, Renata and Eliaschewitz, Freddy and França, Cesar and Genestreti, Paulo Roberto and Grossman, Michele Elka and Hernandes, Mauro and Horta, Ana and Manenti, Euler Roberto and Marques, Mariana and Mothé, Flávia and Moura, Philip and Moura Jorge, José Carlos and Nakashima, Carlos and Nakazone, Marcelo and Napoli, Thiago and Pizzato, Patricia and Reis, Heleno and Ribas Fortes, Jose and Rossi dos Santos, Fabio and Santos, Thiago and Teireira, M and Dimitrov, Georgi and Dimova, Kameliya and Dragoychev, Tsvetan and Grigorova, Valentina and Ivanov, Ivaylo and Kurktschiev, Dimo and ... and REWIND Investigators
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Stroke - prevention & control | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Cardiovascular Diseases - mortality | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Evidence-based medicine | Risk factors | Incidence | Randomization | Older people | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
by Vinereanu, Dragos and Lopes, Renato D and Bahit, M Cecilia and Xavier, Denis and Jiang, Jie and Al-Khalidi, Hussein R and He, Wensheng and Xian, Ying and Ciobanu, Andrea O and Kamath, Deepak Y and Fox, Kathleen A and Rao, Meena P and Pokorney, Sean D and Berwanger, Otavio and Tajer, Carlos and de Barros e Silva, Pedro G M and Roettig, Mayme L and Huo, Yong and Granger, Christopher B and Carbajales, Justo and Gómez, Javier Neri Ceferino and Principato, Mario Bruno and Von Wulffen, María Alejandra and Acunzo, Jorge Galperín Rafael Salvador and Bonato, Ricardo Renato and Ciampi, Natalia and Marani, Alberto Babil and Panigadi, Cristian Gustavo and Pastura, Silvia Gabriela and Onetto, Leonardo Martín and Moya, Cecilia Rafaela and Budassi, Nadia and Valle, Marisol and Camerini, Daniel and Monjes, Enrique and Zabala, Federico and Ricart, Juan Pablo and Medesani, Luis and Campos, Eduardo Noe Ortuño and Ferroni, Fabián and Torres, Mariana Foa and Fassi, Daniel Omar and Bosio, Fernando Javier Díaz and Baztarrica, Gabriel Edgardo Pérez and Infantas, Teresa Zúñiga and Perlo, Daniela and García, Celso Fernando and Durán, Rubén García and Durán, Luisina García and Pettinari, Cecilia Alejandra and Vico, Marisa Liliana and Lanchiotti, Paulina Virginia and Gómez, Mariela Soledad and Poy, Carlos Alberto and Grazziani, Franco Sebastián and Laspina, Marcela Julieta and Poy, María Laura and Bahit, María Cecilia and Tajer, Carlos and García, Marilia and Lopes, Renato D and de Barros e Silva, Pedro Gabriel Melo and Berwanger, Otavio and Egydio, Flávia and Restelli, Elissa and Kawakami, Anelise and Soares, Tamara Colaiácovo and Valois, Mayara Vioto and Duarte, Tauane Bello and Barbosa, Lilian Mazza and de Paola, Angelo Amato Vicenzo and Pimenta, Thiago Librelon and Jeronimo, Gabriela Dal Moro and da Costa, Bruna S. Fernandes and Coutinho, Enia Lucia and Guerrero, Andressa Zulmira A and Maia, Lilia Nigro and Nakazone, Marcelo Arruda and Lemos, Maria Angelica Teixeira and Costa, Osana Maria Coelho and Demore, Ana Paula and Brito, Roberta Parra and Melo, Camila Dal Bon and Góes, Nadielly Codonho and Lorenço, Osvaldo and Gonçalves, Luiz Otavio Maia and Nishiama, Kátia and de Lima, Tiago Aparecido Maschio and Backes, Luciano Marcelo and de Lima Deucher, Keyla Liliana Alves and Rodrigues, Milena Pozzatto and Baldissera, Dunnia Monisa and Reolão, José Basileu Caos and dos Santos, Tais Alves and Freisleben, Fernanda Michel Birck and da Silveira Kaross, Níncia Lucca and Montovani, Jéssika Tzervieczenski and Cantarelli, Maiara and Lucion, Aline and do Amarante, Luciano and ... and IMPACT-AF investigators and IMPACT-AF Investigators
The Lancet (British edition), ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1737 - 1746
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Education, Medical, Continuing | Prospective Studies | Romania - epidemiology | Drug Utilization - trends | Humans | Middle Aged | Argentina - epidemiology | Male | Feedback | Female | Stroke - epidemiology | Brazil - epidemiology | Patient Education as Topic | Anticoagulants | Stroke - prevention & control | Hemorrhage - epidemiology | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | India - epidemiology | China - epidemiology | Medication Adherence | Atrial Fibrillation - epidemiology | Aged | Hemorrhage - chemically induced | Atrial fibrillation | Anticoagulants (Medicine) | Studies | Intervention | Cardiac arrhythmia | Stroke | Fibrillation | Coagulation | Clinical trials | Drug therapy | Evidence-based medicine | Hypertension | Heart attacks | Embolisms | Health risks | Systematic review | Patients | Clinical outcomes | Data capture | Randomization | Patient education | Education | Quality control | Electrocardiography | Clusters | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
by Dagenais, Gilles R and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Riddle, Matthew C and Rydén, Lars and Dyal, Leanne and Chung, Namsik and Conget, Ignacio and Cushman, William C and Hancu, Nicolae and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Lanas, Fernando and Cardona Munoz, Ernesto German and Pogosova, Nana and Shaw, Jonathan E and Temelkova-Kurktschiev, Theodora and Alebuena, Andrea and Almagro, Sandra and Bustamante Labarta, Miguel and Bustos, Betina and Cantero, Maria and Costamagna, Osvaldo and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dominguez, Andrea and Fernandez, Alberto and Gallardo, Karina Beatriz and Garcia Duran, Ruben and Gerbaudo, Claudio and Giotto, Ana Paula and Godoy Bolzán, Pedro and Hermida, Sonia and Hrabar, Adrian and Ingaramo, Adrián and Krynski, Mario and Lagrutta, Mariana and Lanchiotti, Paulina and Matias, Re and Pruyas, Lorena and Ricotti, Carola and Rodriguez, Carolina and Romero Vidomlansky, Mariano and Ronderos, Ricardo and Sadowski, Ana Laura and Sala, Jorgelina and Sernia, Virginia and Sicer, Maximiliano and Smith, Tomas and Stival, Jorge and Vallejos, Julio and Virgillito, Luciana and Vogel, Daniel and Zucchiatti, Noemi and Colquhoun, David and Davis, Timothy and Fourlanos, Spiros and Jeffries, William and Lo, Clement and Makepeace, Ashley and Marope, Dolly and Pillai, Satish and Reutens, Anne and Sheikh, Abdul and Smith, Greg and Castro, Denise Ludovico da Costa de and Correa da Cruz, Ivan and Costa, Midiã and Cunha, Sidney and de Carvalho Camara Bona, Renata and Eliaschewitz, Freddy and França, Cesar and Genestreti, Paulo Roberto and Grossman, Michele Elka and Hernandes, Mauro and Horta, Ana and Manenti, Euler Roberto and Marques, Mariana and Mothé, Flávia and Moura, Philip and Moura Jorge, José Carlos and Nakashima, Carlos and Nakazone, Marcelo and Napoli, Thiago and Pizzato, Patricia and Reis, Heleno and Ribas Fortes, Jose and Rossi dos Santos, Fabio and Santos, Thiago and Teireira, M and Dimitrov, Georgi and Dimova, Kameliya and Dragoychev, Tsvetan and Grigorova, Valentina and Ivanov, Ivaylo and Kurktschiev, Dimo and Miletieva, Milena and ... and REWIND Investigators
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Albuminuria - prevention & control | Creatinine - urine | Glomerular Filtration Rate - drug effects | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Glucagon-Like Peptides - analogs & derivatives | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Evidence-based medicine | Risk factors | Incidence | Randomization | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
by Bentley-Lewis, Rhonda, MD and Aguilar, David, MD and Riddle, Matthew C., MD and Claggett, Brian, PhD and Diaz, Rafael, MD and Dickstein, Kenneth, MD, PhD and Gerstein, Hertzel C., MD and Johnston, Peter, MD and Køber, Lars V., MD and Lawson, Francesca, MD and Lewis, Eldrin F., MD and Maggioni, Aldo P., MD and McMurray, John J.V., MD and Ping, Lin, MD and Probstfield, Jeffrey L., MD and Solomon, Scott D., MD and Tardif, Jean-Claude, MD and Wu, Yujun, PhD and Pfeffer, Marc A., MD, PhD and ELIXA Investigators
The American heart journal, ISSN 0002-8703, 2015, Volume 169, Issue 5, pp. 631 - 638.e7
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular Diseases | Double-Blind Method | Humans | Middle Aged | Male | Peptides - pharmacology | Acute Coronary Syndrome - drug therapy | Glucagon-Like Peptide 1 - agonists | Protein Kinase Inhibitors - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Placebos | Female | Aged | p38 Mitogen-Activated Protein Kinases - metabolism | Research Design | Peptides - therapeutic use | Type 2 diabetes | Glucagon | Coronary heart disease | Analysis | Cardiovascular disease | Heart attacks | Acute coronary syndromes | Mortality | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
by Castellsagué, Xavier and Alemany, Laia and Quer, Miquel and Halec, Gordana and Quirós, Beatriz and Tous, Sara and Clavero, Omar and Alòs, Llúcia and Biegner, Thorsten and Szafarowski, Tomasz and Alejo, Maria and Holzinger, Dana and Cadena, Enrique and Claros, Edith and Hall, Gillian and Laco, Jan and Poljak, Mario and Benevolo, Maria and Kasamatsu, Elena and Mehanna, Hisham and Ndiaye, Cathy and Guimerà, Núria and Lloveras, Belen and León, Xavier and Ruiz-Cabezas, Juan C and Alvarado-Cabrero, Isabel and Kang, Chang-Suk and Oh, Jin-Kyoung and Garcia-Rojo, Marcial and Iljazovic, Ermina and Ajayi, Oluseyi F and Duarte, Flora and Nessa, Ashrafun and Tinoco, Leopoldo and Duran-Padilla, Marco A and Pirog, Edyta C and Viarheichyk, Halina and Morales, Hesler and Costes, Valérie and Félix, Ana and Germar, Maria Julieta V and Mena, Marisa and Ruacan, Arzu and Jain, Asha and Mehrotra, Ravi and Goodman, Marc T and Lombardi, Luis Estuardo and Ferrera, Annabelle and Malami, Sani and Albanesi, Estela I and Dabed, Pablo and Molina, Carla and López-Revilla, Rubén and Mandys, Václav and González, Manuel E and Velasco, Julio and Bravo, Ignacio G and Quint, Wim and Pawlita, Michael and Muñoz, Nubia and Sanjosé, Silvia De and Xavier Bosch, F and ICO Int HPV Head Neck Canc Study and ICO International HPV in Head and Neck Cancer Study Group
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 06/2016, Volume 108, Issue 6, pp. djv403 - djv403
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Predictive Value of Tests | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Papillomaviridae - genetics | Cyclin D1 - analysis | Tumor Suppressor Protein p53 - analysis | Human papillomavirus 16 - isolation & purification | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Infections - complications | Cross-Sectional Studies | Biomarkers, Tumor - analysis | Carcinoma, Squamous Cell - chemistry | Genotype | International Cooperation | Oropharyngeal Neoplasms - virology | Salivary Proline-Rich Proteins - analysis | Papillomaviridae - isolation & purification | Oropharyngeal Neoplasms - chemistry | Aged | Care and treatment | Head and neck cancer | Development and progression | Diagnosis | Biological markers | Papillomavirus infections | Identification and classification | Index Medicus | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Biliary sphincterotomy reduces the risk of acute gallstone pancreatitis recurrence in non-candidates for cholecystectomy
by García de la Filia Molina, Irene and García García de Paredes, Ana and Martínez Ortega, Antonio and Marcos Carrasco, Natalia and Rodríguez De Santiago, Enrique and Sánchez Aldehuelo, Rubén and Foruny Olcina, Jose Ramón and González Martin, Juan Ángel and López Duran, Sergio and Vázquez Sequeiros, Enrique and Albillos, Agustín
Digestive and liver disease, ISSN 1590-8658, 11/2019, Volume 51, Issue 11, pp. 1567 - 1573
Gallstones | Biliary sphincterotomy | Recurrence | Endoscopic retrograde cholangiopancreatography | Pancreatitis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Medicine, Experimental | Medical research | Comorbidity | Surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights